Contrary to LOF mutations that strip the tumor-suppressor function of p53, GOF mutations can turn p53 into an oncogene capable of disrupting cell-cycle control, modulating metabolism, inducing genomic instability, heightening differentiation, forming cancer stem cells, facilitating metastasis, and developing resistance to therapy [127, 130, 131]. Here, TP53 is linked to cancer.